Editorial: Hallmark of cancer: Resisting cell death
Main Authors: | Yichao Zhu, Risheng Yang, Jacqueline H. Law, Muhammad Khan, Kenneth W. Yip, Qiang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1069947/full |
Similar Items
-
Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment
by: Xianghou Xia, et al.
Published: (2023-07-01) -
Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy
by: Yun Chen, et al.
Published: (2020-02-01) -
Entosis: The emerging face of non-cell-autonomous type IV programmed death
by: Isabelle Martins, et al.
Published: (2017-06-01) -
Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance
by: Dandan Wang, et al.
Published: (2020-05-01) -
Cell Death by Entosis: Triggers, Molecular Mechanisms and Clinical Significance
by: Mostafa Kianfar, et al.
Published: (2022-04-01)